Oxea reorganizes syngas and hydrogen supply
Agreement with Air Liquide for the supply of syngas
This agreement enables Oxea to improve its planning security in terms of costs and further position itself in the dynamic growth market of oxo-derivatives. Furthermore, the company's decision to no longer manufacture its own syngas and hydrogen accelerates the expansion and optimization of the product portfolio as well as the geographical expansion into growth markets.
With its 26 employees, the syngas plant produces both synthesis gas and hydrogen. All staff will be permanently employed by Air Liquide at terms that go beyond what is usually agreed in terms of protecting existing employment contracts. The parties agreed not to disclose further details of the agreement.
Since August 2009, when Oxea acquired an ester plant in Amsterdam, it has stepped up its efforts regarding an expansion of the portfolio of oxo-derivatives. The company did not just test and manufacture new products, which are already in great demand in the market, but also continued to invest in existing facilities in order to create additional capacities. In this respect, there is a series of projects not just at the company's largest site, Ruhrchemie in Oberhausen, but other Oxea locations are also conducting research for promising expansions. As a result, Oxea has been systematically pursuing its strategy of extending the value chain and strengthening oxo-derivatives for years.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.